Zota Health Care receives licnese for Zotamet and Telmisartan in Kyrgyzstan

Zota Health Care Limited have received product registration licenses for two products – Zotamet 1000 (Metformin Tablets BP 1000 mg) Antidiabetic and CDTEL-40 (Telmisartan Tablets USP 40 mg) Angiotensin II Antagonists from the Department of Medicines And Medical Devices under the Ministry of Health of the Kyrgyz Republic, Kyrgyzstan.

The company has received product registration licenses for five years validity, further, the same can be renewed after expiration. The company shall commence export of these products in Kyrgyzstan in near term.